John Welch, Butterworth Laboratories, urges pharmaceutical manufacturers to prepare sooner rather than later for the impending changes to elemental impurities requirements
Scientists have identified that glucose fuels the growth of cancer. The particular protein that fuels this growth is PARP14. They hope to create a drug which inhibits PARP 14, starves the cancerous cells and, in the future, can be used to cure cancer
Capsugel’s Steven Facer says prioritisation of quality and regulatory compliance from the start is key to achieving long-term gains for emerging markets
Angle’s Andrew Newland talks to EPM about the high level of interest from across the globe in the company’s cell separation technology, which captures cancer cells circulating in the blood and harvests those cells for analysis
What requirements need to be met by a tablet testing system to guarantee a successful product release? Is it dependable upon the testing system’s quality, speed, technology, flexibility or safety? Kraemer and Ischi explain…
Dr. Paul Clewlow, Sygnature Discovery, talks to EPM about the company’s successful track record in discovering medicines for the benefit of “patients with debilitating diseases such as cancer”
